Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PURSUE: Corifollitropin Alfa for Controlled Ovarian Stimulation
NCT01144416Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2010
- Primary completion
- Jul 2011
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
01
Overview
Phase 3, randomised, double-blind trial of corifollitropin alfa in infertility (2 arms), sponsored by Organon & Co. Primary endpoint: Percentage of Participants With a Vital Pregnancy. Started Jun 2010; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01144416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01144416.